释放药物与瘤后栓塞综合征相关结果之间的关联
Hanzhou Li1, John Moon1, Nathan Sim2
1Department of Radiology and Imaging Sciences, Emory School of Medicine, Atlanta, Georgia, USA.
Cancer medicine
|December 3, 2025
概括
在TACE或TARE后,向肝细胞癌患者提供阿片类药物,抗emetics和类固醇,可显著降低再入院和药物升级风险. 这支持干预瘤学的综合性术后疼痛管理策略.
科学领域:
- 干预性瘤学干预性瘤学
- 肝细胞癌治疗方法 肝细胞癌治疗方法
- 瘤学 药理学 药理学
背景情况:
- 经过动脉化学栓塞 (TACE) 和90放射栓塞 (TARE) 后的后栓塞综合征导致患者的显著发病率.
- 优化出院处方可能会标准化疼痛管理,并改善这些程序后的短期结果.
研究的目的:
- 调查出院处方对TACE和TARE治疗肝细胞癌后短期结果的影响.
- 为了确定特定的药物是否会影响药物升级或重新入院的发生率.
主要方法:
- 3191名患者进行了3988次肝细胞癌手术的回顾性队列研究 (2009-2022年).
- 利用 Merative MarketScan 数据库来获取患者数据和结果.
- 分析了使用多变量逻辑回归分析药物升级或再入院的7天复合结果,并根据患者人口统计和并发症进行调整.
主要成果:
- 出院时的阿片类药物处方与TACE (aOR=0.17) 和TARE (aOR=0.41) 两种药物升级或再录取的几率显著降低.
- 处方抗emetics和类固醇也与减少升级/再接收事件有关,具体关联因手术类型而异.
结论:
- 包括阿片类药物,抗emetics和类固醇在内的出院处方可能会减少治疗后的并发症,如药物升级和重新接收在接受TACE或TARE的肝细胞癌患者.
- 这些发现强调了干预性瘤实践中综合性疼痛管理策略的必要性.
- 对这些处方模式的考虑在未来的临床实践指南中是有必要的.
相关概念视频
01:27Pulmonary Embolism III: Nursing Management
325
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
325
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
281
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
281
01:27Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
576
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
576
01:31Discharge Summary Forms
1.2K
The discharge summary is crucial as it enables a smooth transition from a healthcare facility to a patient's home or another care setting. This critical document facilitates seamless continuity of care, ensuring patients receive the necessary support and attention.
Here's a detailed look at the key components and guidelines for preparing a discharge summary:
Here's a detailed look at the key components and guidelines for preparing a discharge summary:
1.2K
01:28Esophageal Varices-II: Clinical Features and Management
343
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
343
02:49Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K